An interventional study of Citalopram and Clomipramine in Depression, sponsored by University of Aarhus. Completed. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2012-04-11.
Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment
citalopram and clomipramine are better than placebo in preventing new episodes of depression in patients with recurrent depression
8,057 studies on the registry are indexed under Depression; 1,643 are open to participants now.
This study's enrollment of 59 is below the median of 84 across 6,718 interventional studies indexed under Depression.
Browse Depression studies →University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
citalopram
Drug: Citalopram
clomipramine
Drug: Clomipramine
placebo
Drug: placebo
2 Hamilton Depression Rating Scale scores of at least 16 with one weeks interval or initiation of another antidepressant treatment
Time frame: 2 years of follow-up
Study termination due to adverse event or non-compliance
Time frame: 2 years of follow-up
No study locations are listed for this record.
This study is completed, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aarhus